Home » Topics » BioWorld Science

BioWorld Science
RSS

Cardurion Pharmaceuticals synthesizes new CAMK2 inhibitors

April 21, 2020

Genzyme identifies new GALC inhibitors

April 21, 2020

Regenacy Pharmaceuticals discloses HDAC1 and/or HDAC2 inhibitors

April 21, 2020

Arbidol shows superior efficacy compared to lopinavir/ritonavir in treating COVID-19

April 21, 2020

RAPT Therapeutics patents USP7 inhibitors

April 21, 2020

BCH-070, a novel antiparasitic candidate against multidrug-resistant malaria

April 21, 2020

First COVID-19 patient treated under emergency use IND with Stemedica's itMSCs

April 21, 2020

Promising topline data for Xeris' novel intramuscular injection formulation of diazepam

April 21, 2020

Alexion to initiate global phase III study of Ultomiris in severe COVID-19

April 21, 2020

Long noncoding RNA has sex-specific role in depression

April 21, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...